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Abstract
Detection of intestinal protozoa by PCR methods has been
described as being sensitive and speciﬁc, and as improving the
diagnostic yield. Here we present the outcome of the transition
from microscopy to molecular screening for detection of a select
group of intestinal protozoa in faeces in our laboratory.
Introduction of molecular screening for intestinal protozoa
resulted in higher sensitivity, reduced hands-on-time, reduced
time-to-results, leading to improved diagnostic efﬁciency.
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Molecular detection techniques are known to be sensitive and
speciﬁc. The technique is increasingly used in diagnostic medical
microbiological laboratories and replaces classical diagnostic
methods. PCRs for detection of intestinal protozoa have been
described as being sensitive and speciﬁc; moreover, these PCRs
have improved the diagnostic yield [1–4]. Here we describe the
transition from microscopy to molecular screening for detec-
tion of intestinal protozoa in faeces in our laboratory. All
samples were obtained from residents of the Netherlands.
Parasitological examination of faecal samples was performed
by routine microscopy for ova and cysts on a concentrated
faecal sample (Ridley technique). Since 2007, additional
microscopy was performed on two sodium acetate forma-
lin-preserved stool specimens and one unpreserved specimen
in a so-called triple faeces test (TFT), faecal samples being
collected on three consecutive days [5]. In 2010 these routine
microscopy procedures were replaced by a two-tube multi-
plex PCR for detection of Blastocystis [6], Cryptosporidium spp.
[1], Entamoeba sp. [7], Giardia lamblia [4], Dientamoeba fragilis
[8] and an internal control [9]. Faecal specimens for PCR were
processed as described elsewhere [1]. Before introduction of
PCR into routine diagnostics, laboratory validation of the PCR
was performed on 744 faecal samples for G. lamblia and
D. fragilis and 567 faecal samples for Blastocystis, Cryptosporidi-
um spp. and Entamoeba sp. PCR for intestinal protozoa was
introduced in week 27 of year 2009. For the remaining part of
the year both methods were used for diagnostic purposes, in
2010 microscopy was replaced by PCRs. We analysed the
outcome of the transition in terms of diagnostic yield for
protozoa and impact on laboratory procedures.
Requests for parasitological investigation on faeces have
been increasing during the past several years, in particular for
TFT with 1097, 1764 and 2147 requests in 2007, 2008 and
2009, respectively. This expressed the need to ﬁnd a method
that was more suitable to process high numbers of faecal
specimens, like PCR. Therefore, PCRs were developed and
validated, followed by performing an additional laboratory
validation.
During laboratory validation, PCR (performed on tube 2 of
the TFT-set) showed positivity rates of 30%, 33% and 10% for
D. fragilis, Blastocystis and G. lamblia, compared with 28%, 25%
and 9% using microscopy (performed on sodium acetate
formalin-preserved samples from tubes 1 and 3, and on a
concentrated faecal sample from tube 2). Positivity rates for
Entamoeba sp. and Cryptosporidium spp. were both 0.5% for
both methods (Table 1). Diagnosis of D. fragilis by both
methods is noteworthy. Detection by PCR did not show a
remarkable increase in the total number of D. fragilis-positive
samples; however, a large number of specimens were positive
by microscopy and negative by PCR. These specimens were
analysed further and appeared to have a positive signal in PCR
above the cut-off cycle threshold of 40, indicating a low load of
D. fragilis. Microscopy and PCR-negative specimens did not
show positive signals above a cycle threshold of 40. We should
emphasize that PCR was performed on the faecal specimen
from tube 2 of the TFT-set, whereas microscopy for D. fragilis
was performed on tubes 1 and 3 of the TFT-set and was
reported as positive if any of these tubes was positive for
Dientamoeba trophozoites. This ﬁnding (positive by micro-
scopy in tubes 1 and 3, and negative by PCR in tube 2) reﬂects
the irregular shedding of D. fragilis, which is a well-known
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phenomenon [10]. In ﬁve microscopy-positive PCR-negative
specimens, tubes 1 and 3 were tested by PCR and apparently
faecal material from these tubes could produce positive signals
in D. fragilis PCR, while being negative in tube 2. Tubes 1 and 3
included sodium acetate formalin ﬁxative, which can negatively
inﬂuence the quality of DNA, but positive signals were
recorded.
Actual use of PCRs in diagnostics from 2010 onwards showed
lower average positivity rates than those during laboratory
validation. Positivity rates of 26% and 30% forD. fragilis, 29% and
28% for Blastocystis, and positivity rates of 4% for G. lambliawere
seen in 2010 and 2011, respectively. Positivity rates of micros-
copy examination, before starting the laboratory validation,
were also lower: for D. fragilis 10% and 12%, for Blastocystis 12%
and 14%, for G. lamblia 3.3% and 3.5% and for Cryptosporidium
spp. 0.1% and 0.2% in 2008 and 2009, respectively.
Introduction of PCR into diagnostics inﬂuenced laboratory
logistics, as expected. TFT requests were discouraged, result-
ing in 28 and 22 requests in 2010 and 2011. PCR was
performed on one unpreserved, fresh faecal specimen and in
case of suspicion of non-protozoal gastrointestinal parasites or
other protozoa not present in our PCR, microscopy was still
performed and the TFT-set with three tubes was requested
[1]. Introduction of PCR for intestinal protozoa led to an
increase in the total number of faecal specimens submitted for
parasitological diagnosis (Fig. 1).
Although a higher number of specimens had to be
processed and consumable costs for PCR are higher than for
microscopy, the transition from microscopy to PCR was
proﬁtable for both the laboratory and the clients. PCR
diagnostics resulted in a reduction in the hands-on time and
time-to-result. Hands-on time for one TFT-set was around
20 min, whereas in 20 min at least ten specimens can be
processed for PCR, reducing personnel costs for parasitolog-
ical examination. Time-to-result in case of PCR diagnostics was
extremely reduced. For example, 2 days after obtaining a
sample, results from 42% of the samples are reported in the
case of PCR, compared with only 17% of the samples in the
case of microscopy; these values are 91% and 68%, respec-
tively, on day 5.
Increase in requests for TFT expressed the need for a
high-throughput method, and justiﬁed the introduction of PCR
TABLE 1. Overview of the results of laboratory validation as obtained by PCR and microscopy
PCR +/Microscopy + (%) PCR +/Microscopy  (%) PCR /Microscopy + (%) PCR /Microscopy  (%) Total
Blastocystis 142 (25) 45 (7.9) 2 (0.4) 378 (66.7) 567
Cryptosporidium spp. 2 (0.4) 3 (0.5) 0 (0) 562 (99.1) 567
Entamoeba sp. 3 (0.5) 0 (0) 0 (0) 564 (99.5) 567
Giardia lamblia 65 (8.7) 8 (1.1) 1 (0.1) 670 (90.1) 744
Dientamoeba fragilis 156 (21) 69 (9.3) 51 (6.9) 468 (62.9) 744
FIG 1. Number of tested samples by microscopy, triple faeces test (TFT) and PCR from year 2007 to the end of 2011. On the right axis: percentage
of samples positive with any parasite.
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for the detection of intestinal protozoa. Our PCR is limited to
the detection of theDNAof ﬁve protozoa forwhich primers and
probes are included in the multiplex PCR. When predisposing
factors for infection with other protozoa or non-protozoal
intestinal parasites are present, classical microscopy should be
performed. In that case, microscopy is performed on the same
sample, or on a newly requested TFT-set.
As expected, and as shown in other studies, during
laboratory validation PCR showed higher positivity rates
compared with microscopy. Testing of only tube 2 from the
TFT-set in PCR, might give an underestimation of D. fragilis
infections. This was not reported by other studies, and needs
further investigation [1–4].
Before and after the laboratory validation period, micros-
copy and PCR showed lower overall positivity rates than those
found during the validation period. This is most probably due
to testing more specimens that are positive during the
validation period than are present in routine diagnostics, as
positive specimens were included to have a sufﬁcient number
of positive materials.
In conclusion, introduction of the parasite PCR resulted in
higher sensitivity, reduced hands-on-time and time-to-results,
leading to improved diagnostic efﬁciency. We recommend the
introduction of parasite PCR into routine parasitological
practice. This will facilitate larger-scale studies on the preva-
lence and clinical characteristics of protozoal gastrointestinal
infections.
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